Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Novocure (NASDAQ:NVCR) is Profiled in this Database

Updated At 10 Feb, 2011

Start Free 7 Day Trial Now
Partial description of this company
A non-invasive, portable device that treats glioblastomas with low intensity, alternating electrical fields

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Novocure (NASDAQ:NVCR) plus 4924 other startups.

Start Free 7 Day Trial Now

Learn More About Novocure (NASDAQ:NVCR)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy


Our Clients